Loading…
Prism Medico & Pharmacy (BSE 512217)₹36.18+5.21%Non Banking Financial Company (NBFC)
At the end of the Jun 2026 quarter, Prism Medico & Pharmacy's shareholders were: promoters 29.96%, public 70.04%. Promoter holding is up 4.48 percentage points from 25.48% a quarter earlier. 0.00% of promoter shares were pledged. It had 4,176 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 24.98% | 24.98% | 24.98% | 24.98% | 24.98% | 24.98% | 24.98% | 24.98% | 24.98% | 24.98% | 25.48% | 29.96% |
| Public | 75.02% | 75.02% | 75.02% | 75.02% | 75.02% | 75.02% | 75.02% | 75.02% | 75.02% | 75.02% | 74.52% | 70.04% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 3,464 | 3,649 | 3,791 | 3,865 | 4,106 | 4,177 | 4,301 | 4,305 | 4,314 | 4,305 | 4,294 | 4,176 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Dharmender Kharb | Public | 19.36% | New |
| Symbiosis Pharmaceuticals Private Limited | Promoter | 15.64% | +1.66 |
| Galaxy Vitacare Private Limited | Promoter | 13.23% | +4.63 |
| Raju Tyagi | Public | 9.73% | New |
| Sejal S Nashatar | Public | 2.52% | New |
| Shilpa Harsh Rupareliya | Public | 2.45% | New |
| Harsh Jentibhai Rupareliya | Public | 2.44% | New |
| Anshul Jajoo | Public | 1.41% | −0.71 |
| Bosco Armando Menezes | Public | 1.12% | −1.36 |
| Emily Bosco Menezes | Public | 1.12% | −1.36 |
| Ramit Walia | Promoter | 1.08% | −1.33 |
| Reeta Devi | Public | 1.02% | −1.27 |
| Anil Kumar | Public | Exited | — |
| Mouna M Jain | Public | Exited | — |
| Anilkumar . | Public | Exited | — |
| Miral Hemantbhai Bhoot | Public | Exited | — |
| Jasjot Singh | Promoter | Exited | — |
Promoters held 29.96% of Prism Medico & Pharmacy at the end of the Jun 2026 quarter, up 4.98 percentage points from 24.98% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Prism Medico & Pharmacy had 4,176 shareholders at the end of the Jun 2026 quarter, against 4,305 a year earlier.
Dharmender Kharb (Public) held 19.36% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.